MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Diabetes Platform Dubbed Best mHealth App

Image courtesy of Gendius Diabetes
Gendius was recognized for "Best mHealth Application" at the Health Tech Digital Awards 2020 for its diabetes management platform, Intellin.

Gendius announced this week that it won the "Best mHealth Application" award at the Health Tech Digital Awards 2020 with its diabetes remote management platform, Intellin. The Intellin platform is designed to help people with diabetes track and monitor their condition. The platform analyzes patients’ clinical history and metabolic markers to forecast their risk for developing serious diabetes-related complications.

“We are thrilled that our Intellin platform has been recognized as the leading mHealth application for 2020 by the Health Tech Digital expert judges," said Gendius CEO Rory Cameron. "With the unique healthcare challenges that have been thrown up by COVID-19, remote management technology is now more important than ever, especially for long-term conditions like diabetes. We have some exciting new developments on the horizon for Intellin, which are going to give people with diabetes even more tools to monitor and control their condition.”

Launched in January 2020, Intellin has already seen outstanding growth, with over 375,000 downloads worldwide, and more than 70,000 monthly active users. It is one of the top scoring diabetes apps in the ORCHA app library and has been welcomed as an exciting development in diabetes care by clinicians, according to the company.

In a review of Intellin, in collaboration with the Organization for the Review of Care and Health Apps, Tom Micklewright, MD, called Intellin "the FitBit of diabetes apps."

"It is an incredibly comprehensive tracking tool for monitoring a huge range of different variables that matter to diabetics," Micklewright said. "The most valuable bit is you can go to the priorities section off the app. What the priorities section does, is draw all of the information from the tracking you have done together to highlight your highest risk areas as a diabetic. It flags the high-risk areas, explains that risk, and then offers tailored advice to the patient."

Gendius said it recently entered into a strategic partnership with AstraZeneca in the Gulf region. The partnership will see healthcare professionals across the Gulf using the Intellin platform to optimize their patients’ diabetes management, the company said.

Click here to see the full list of winners for Health Tech Digital Awards 2020.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish